Literature DB >> 28378175

Pantothenate kinase associated neurodegeneration (Hallervorden - Spatz syndrome).

Seema Kapoor1, Konstanze Hörtnagel2, Siddhartha Gogia3, Ritu Paul3, Vishal Malhotra3, Anjali Prakash3.   

Abstract

Hallervorden-Spatz syndrome is a rare autosomal recessive hereditary condition characterized by early onset of progressive movement alteration that include dystonia, rigidity and choreoathetosis usually associated with pyramidal signs and mental deterioration. We report two sisters where diagnosis was missed till MRI showed classic imaging findings. Mutation analysis in one, revealed homozygous mutations in the PANK 2 gene. The need for clinical recognition of this entity and differentiation of this form from other static and progressive neurological illnesses is emphasized.

Entities:  

Keywords:  Hallervorden-spatz syndrome; PANK 2 gene; Pantothenate kinase associated neurodegeneration

Year:  2005        PMID: 28378175     DOI: 10.1007/BF02859271

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  8 in total

1.  Hallervorden-Spatz disease: two new early childhood onset cases.

Authors:  J A Peña; O Molina; J Cardozo
Journal:  J Child Neurol       Date:  2000-01       Impact factor: 1.987

2.  Hallervorden Spatz syndrome (pantothenate kinase associated neurodegeneration) in two Sardinian brother with homozygous mutation in PANK 2 gene.

Authors:  Giovanni Cossu; Maurizio Melis; Gianluca Floris; Susan J Hayflick; Andrea Spissu
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

3.  Naming of syndromes and unethical activities: the case of Hallervorden and Spatz.

Authors:  P S Harper
Journal:  Lancet       Date:  1996-11-02       Impact factor: 79.321

4.  Pantothenate kinase regulation of the intracellular concentration of coenzyme A.

Authors:  C O Rock; R B Calder; M A Karim; S Jackowski
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

5.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.

Authors:  B Zhou; S K Westaway; B Levinson; M A Johnson; J Gitschier; S J Hayflick
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

6.  An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria.

Authors:  Konstanze Hörtnagel; Holger Prokisch; Thomas Meitinger
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

7.  Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.

Authors:  Susan J Hayflick; Shawn K Westaway; Barbara Levinson; Bing Zhou; Monique A Johnson; Katherine H L Ching; Jane Gitschier
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

8.  Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.

Authors:  Madhavi Thomas; Susan J Hayflick; Joseph Jankovic
Journal:  Mov Disord       Date:  2004-01       Impact factor: 10.338

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.